Sonia G. Tanlimco

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson et al. · Cancer Research · 2018 · 189 citations

Immune oncology, immune responsiveness and the theory of everything

Tolga Turan, Deepti Kannan, Maulik Patel et al. · Journal for ImmunoTherapy of Cancer · 2018 · 80 citations · Full text

Disruption of a Single <i>Pten</i> Allele Augments the Chemotactic Response of B Lymphocytes to Stromal Cell-Derived Factor-1

Joanne Fox, Karen Ung, Sonia G. Tanlimco et al. · The Journal of Immunology · 2002 · 43 citations · Full text

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb

Debra T. Chao, Mian Su, Sonia G. Tanlimco et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 36 citations · Full text

Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR

James W. Purcell, Han K. Kim, Sonia G. Tanlimco et al. · Frontiers in Immunology · 2014 · 15 citations · Full text